Funding shortfalls prompt 18 states to cut costs, jeopardizing care for tens of thousands of Americans living with HIV.

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

Mr Ghebreyesus said a new medicine approved in 2025 for HIV prevention, Lenacapavir, represents the most significant development in combating HIV since the first antiretroviral treatments were ...

Federal data shows the NIH lost about 4,400 people — more than 20% of its workforce. Scientists say the departures harm the U.S.’ ability to respond to disease outbreaks, develop treatments for ...

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...